George Vlachogiannis/LinkedIn
Jun 10, 2025, 21:07
George Vlachogiannis: New Insights into Brain Metastasis in Pancreatic Cancer Patients
George Vlachogiannis, Managing Editor – Cancer Control at Sage, shared an article on LinkedIn:
“Clinical Characteristics and Survival in Patients with Brain Metastases From Pancreatic Cancer: A Retrospective Observational Study. Brain metastasis is a rare but critical manifestation of pancreatic cancer.
In a retrospective study of over 900 patients with pancreatic cancer, brain metastasis was identified in 3.7%. Notably, in 41% of these cases, the brain was the first site of metastasis.
This retrospective observational study published in Cancer Control provides real-world data on the characteristics and survival of patients with brain metastasis from pancreatic cancer. Findings suggest that early neuroimaging in high-risk patients may enable earlier detection, potentially improving survival outcomes.”
Title: Clinical Characteristics and Survival in Patients with Brain Metastases From Pancreatic Cancer: A Retrospective Observational Study
Authors: Susan Haag, Derek Cridebring
Read the Full Article.
More posts featuring George Vlachogiannis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 11, 2025, 00:00
Jun 10, 2025, 18:19